Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies

Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies

Abstract Background Case reports, retrospective analyses, and observational studies have linked the use of cisplatin to increased risk of second cancers, especially life-threatening secondary leukemia. We therefore performed a systematic review and meta-analysis to evaluate the risk of second cancer...

Full description

Bibliographic Details
Main Authors: Fei Liang, Sheng Zhang, Hongxi Xue, Qiang Chen
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Cancer
Subjects:
Second cancer
Cisplatin
Randomized controlled trials
Online Access:http://link.springer.com/article/10.1186/s12885-017-3902-4

Similar Items

Similar Items